AIMD Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 23:00):

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications...

Stats
Dzisiejszy wolumen	139 675
Średni wolumen	1.44M
Kapitalizacja rynkowa	6.51M
EPS	$0 ( 2024-03-29 )
Następna data zysków	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.320
ATR14	$0.0100 (0.91%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-18	Lee Hsin-liang Christopher	Buy	0
2024-02-16	Lee Ting-chuan	Sell	14 400	RSU
2024-02-16	Lee Ting-chuan	Buy	14 400	CommonStock
2024-02-16	Sung Meng Lin	Buy	1 050	Common Stock
2024-02-16	Sung Meng Lin	Sell	1 050	RSU

INSIDER POWER
23.28
Last 95 transactions
Buy: 22 138 064 \| Sell: 12 377 869

Ainos, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ainos, Inc. Finanse

Annual	2023
Przychody:	$122 112
Zysk brutto:	$-5.11M (-4 181.56 %)
EPS:	$-3.36

FY	2023
Przychody:	$122 112
Zysk brutto:	$-5.11M (-4 181.56 %)
EPS:	$-3.36

FY	2022
Przychody:	$3.52M
Zysk brutto:	$1.41M (39.93 %)
EPS:	$-5.15

FY	2021
Przychody:	$594 563
Zysk brutto:	$410 382 (69.02 %)
EPS:	$-0.0300

Financial Reports:

No articles found.

Ainos, Inc.

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.

Aktualne aktualizacje dla Ainos, Inc. [AIMD]

Upcoming Earnings Alert